Arylsulfonamide agonists of the human beta 3 adrenergic receptor for the treatment of obesity.

被引：0

作者：

Weber, AE ^{[1
]}

Mathvink, RJ ^{[1
]}

Hutchins, JE ^{[1
]}

Perkins, LM ^{[1
]}

Parmee, ER ^{[1
]}

Ok, HO ^{[1
]}

Candelore, MR ^{[1
]}

Vicario, PP ^{[1
]}

Cascieri, MA ^{[1
]}

Strader, CD ^{[1
]}

Hom, GJ ^{[1
]}

Forrest, MJ ^{[1
]}

MacIntyre, DE ^{[1
]}

Alvaro, RF ^{[1
]}

Kao, J ^{[1
]}

Wyvratt, MJ ^{[1
]}

Fisher, MH ^{[1
]}

机构：

[1] MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 213卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：168 / MEDI

页数：1

共 50 条

[41] INHIBITION OF THE LIPOLYTIC ACTION OF BETA-ADRENERGIC AGONISTS IN HUMAN ADIPOCYTES BY ALPHA-ADRENERGIC AGONISTS
WRIGHT, EE
SIMPSON, ER
JOURNAL OF LIPID RESEARCH, 1981, 22 (08) : 1265 - 1270
[42] Modeling and Simulation Studies of Human β3 Adrenergic Receptor and its Interactions with Agonists
Sahi, Shakti
Tewatia, Parul
Malik, Balwant K.
CURRENT COMPUTER-AIDED DRUG DESIGN, 2012, 8 (04) : 283 - 295
[43] Beta-adrenergic-receptor-agonists/muscarinic-receptor-agonists/nintedanibNo improvement: case report
Reactions Weekly, 2024, 2025 (1) : 86 - 86
[44] Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity
Lafontaine, Jennifer A.
Day, Robert F.
Dibrino, Joe
Hadcock, John R.
Hargrove, Diane M.
Linhares, Michael
Martin, Kelly A.
Maurer, Tristan S.
Nardone, Nancy A.
Tess, David A.
DaSilva-Jardine, Paul
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5245 - 5250
[45] Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor
Fletcher, DS
Candelore, MR
Grujic, D
Lowell, BB
Luell, S
Susulic, VS
MacIntyre, DE
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (02): : 720 - 724
[46] Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs.: I.: The presence of canine β3-adrenergic receptor and in vivo lipomobilization by its agonists
Sasaki, N
Uchida, E
Niiyama, M
Yoshida, T
Saito, M
JOURNAL OF VETERINARY MEDICAL SCIENCE, 1998, 60 (04): : 459 - 463
[47] β1β2 adrenergic receptor (AR) double knockout mice exhibit mild obesity.
Din, N
Sorensen, A
Hamilton, BS
Ploughstrup, P
OBESITY RESEARCH, 2000, 8 : 115S - 115S
[48] Regulation of the Human Growth Hormone Receptor (GHR) Expression in Obesity.
Erman, A.
Goodyer, C. G.
ENDOCRINE REVIEWS, 2010, 31 (03)
[49] β2 Adrenergic Receptor Agonists as a Novel Treatment for CKD
Arif, Ehtesham
Medunjanin, Danira
Solanki, Ashish K.
Zuo, Xiaofeng
Su, Yanhui
Winkler, Brennan
Palygin, Oleg
Cornier, Marc-Andre
Wolf, Bethany
Hunt, Kelly J.
Lipschutz, Joshua H.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 109 - 109
[50] Selective β3 adrenergic receptor agonist for the treatment of obesity and NIDDM.
Rito, CJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U111 - +

← 1 2 3 4 5 →